| Literature DB >> 33022957 |
Sachiko Maruya1, Ribeka Takachi1, Maki Kanda1, Misako Nakadate2, Junko Ishihara2.
Abstract
Salt intake reduction is crucial to prevent non-communicable diseases (NCDs) globally. This study aimed to investigate the short- and long-term effects of monitoring salt concentration in homemade dishes on reducing salt intake in a Japanese population. A double-blind randomized controlled trial using a 2 × 2 factorial design with two interventions was conducted in 195 participants; they were assigned to both interventions for a group monitoring salt concentration in soups (control: no monitoring) and a group using low-sodium seasoning (control: regular seasoning). We evaluated 24-hour urinary sodium excretions at baseline and after a three-month intervention for the changes as major outcomes, at six- and twelve-months after baseline as long-term follow-up surveys. Urinary sodium excretion decreased in both intervention and control groups after the intervention. However, differences in the change for both monitoring and low-sodium seasoning interventions were statistically non-significant (p = 0.29 and 0.52, respectively). Urinary sodium excretion returned to the baseline level after twelve-months for all groups. Monitoring of salt concentration is ineffective in reducing salt intake for short- and long-term among the people studied in this cohort.Entities:
Keywords: food preference; randomized control trial; sodium
Mesh:
Substances:
Year: 2020 PMID: 33022957 PMCID: PMC7600707 DOI: 10.3390/nu12103034
Source DB: PubMed Journal: Nutrients ISSN: 2072-6643 Impact factor: 5.717
Figure 1Study scheme. * Excluded for incomplete urine collection. ** Excluded for use of hypertensive medicine.
Baseline characteristics of participants.
| Monitoring Intervention | Seasoning Intervention | |||||
|---|---|---|---|---|---|---|
| Control Group | Intervention Group |
| Control Group | Intervention Group |
| |
| Sex (% females) | 62.6 | 67.7 | 0.46 | 62.0 | 68.0 | 0.38 |
| Age 2) | 47.2 (11.3) | 47.8 (10.3) | 0.68 | 47.6 (10.7) | 47.4 (10.9) | 0.92 |
|
| 0.79 | 0.77 | ||||
| None | 77.8 | 75.0 | 78.3 | 74.8 | ||
| Prior smoking history | 15.2 | 18.8 | 16.3 | 17.5 | ||
| Current smoker | 7.0 | 6.3 | 5.4 | 7.8 | ||
|
| 0.72 | 0.47 | ||||
| None | 23.2 | 28.1 | 25.0 | 26.2 | ||
| Occasionally | 45.5 | 43.8 | 48.9 | 40.8 | ||
| Every day | 31.3 | 28.1 | 26.1 | 33.0 | ||
| Current medication status (% currently) 3) | 23.2 | 14.6 | 0.12 | 22.8 | 15.5 | 0.20 |
|
| 0.19 | 0.56 | ||||
| Eastern region in Japan | 57.1 | 42.9 | 44.2 | 55.9 | ||
| Western region in Japan | 46.6 | 53.4 | 49.2 | 50.9 | ||
| Weight (kg) 2) | 59.0 (12.7) | 58.9 (11.0) | 0.95 | 59.4 (12.2) | 58.6 (11.6) | 0.64 |
| Urinary sodium excretion (mg/day) 2) | 3908 (1581) | 3,905 (1452) | 0.99 | 4166 (1723) | 3675 (1265) | 0.03 |
|
| ||||||
| miso soup (% 5 bowls or more /week) | 62.6 | 60.4 | 0.75 | 60.8 | 62.1 | 0.86 |
| taste preference | 9.1 | 4.1 | 0.17 | 7.6 | 5.8 | 0.62 |
| noodle soup (% take one third or more) | 75.8 | 63.4 | 0.06 | 71.7 | 68.0 | 0.57 |
| pickles (% 3 times or more /week) | 32.3 | 30.2 | 0.75 | 38.0 | 25.2 | 0.05 |
| soy sauce using at table (% using) | 57.6 | 58.3 | 0.91 | 60.9 | 55.3 | 0.44 |
| salt using at table (% using) | 32.3 | 32.3 | 1.00 | 32.6 | 32.0 | 0.93 |
1)t-tests for age, weight, and urinary sodium excretion. Chi-squared test for sex, smoking history, alcohol intake, current medication status, residential area, and dietary habits. 2) Mean (standard deviation, SD); 3) excluding hypertension drugs.
Changes in urinary sodium excretion, and differences between the intervention and control groups (mg/day).
| Intervention Group | Control Group | Difference of Change 4) |
| Difference of Change 6) |
| |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
| Baseline 1) | Post Intervention 1) | Change 2) | Change 3) |
| Baseline 1) | Post Intervention 1) | Change 2) | Change 3) | |||||
| Monitoring intervention | ||||||||||||||
| At the end of the intervention | 91 | 4004 | 3750 | −255 | −132 8) | 97 | 3887 | 3412 | −475 | −384 8) | 220 | 0.37 | 253 8) | 0.29 |
| (1422) | (1449) | (−571, 62) | (−561, 297) | (1590) | (1313) | (−837, −112) | (−763, −5) | (−261, 701) | (−235, 741) | |||||
| 6 months after the baseline | 94 | 3950 | 3626 | −324 | −242 8) | 95 | 3860 | 3659 | −201 | −139 8) | −123 | 0.64 | −103 8) | 0.72 |
| (1431) | (1428) | (−657, 9) | (−690, 206) | (1570) | (1542) | (−584, 182) | (−546, 267) | (−627, 382) | (−619, 413) | |||||
| 12 months after the baseline | 91 | 3931 | 3898 | -33 | 10 8) | 92 | 3874 | 3736 | −138 | −76 8) | 105 | 0.65 | 86 8) | 0.71 |
| (1448) | (147) | (−314, 248) | (−394, 415) | (1604) | (1487) | (−499, 222) | (−443, 291) | (−349, 560) | (−384, 557) | |||||
| Seasoning intervention | ||||||||||||||
| At the end of the intervention | 101 | 3714 | 3427 | −287 | −297 9) | 87 | 4210 | 3747 | −463 | −173 9) | 176 | 0.47 | −123 9) | 0.52 |
| (1244) | (1384) | (−607, 34) | (−617, 23) | (1735) | (1379) | (−830, −95) | (−492, 146) | (−306, 656) | (−512, 264) | |||||
| 6 months after the baseline | 99 | 3696 | 3557 | −139 | −194 9) | 90 | 4134 | 3736 | −398 | −166 9) | 259 | 0.31 | −28 9) | 0.89 |
| (1241) | (1528) | (−463, 185) | (−545, 157) | (1717) | (1432) | (−793, −3) | (−510, 178) | (−246,763) | (−450, 393) | |||||
| 12 months after the baseline | 94 | 3660 | 3666 | 6 | −54 9) | 89 | 4159 | 3975 | −184 | 9 9) | 190 | 0.41 | −64 9) | 0.76 |
| (1247) | (1352) | (−323, 336) | (−394, 285) | (1742) | (1746) | (−499, 131) | (−319, 338) | (−264, 644) | (−473, 345) | |||||
1) Mean (SD); 2) mean (95% confidence interval, CI), change = post-intervention urinary sodium excretion − baseline urinary sodium excretion (mg/day); 3) least square, LS means (95% CI), change = post-intervention urinary sodium excretion − baseline urinary sodium excretion (mg/day); 4) mean (95% CI), difference of change = change in intervention group − change in control group; 5) t-tests; 6) LS means (95% CI), difference of change = change in intervention group − change in control group; 7) analysis of covariance; 8) adjusted for sex, alcohol drinking habits, current medication status, residential areas, other intervention, and interaction term of the interventions; 9) adjusted for sex, alcohol drinking habits, current medication status, residential areas, other intervention, baseline urinary sodium excretion, and interaction term of the interventions.
Figure 2Changes in urinary sodium excretion for each intervention (mean based on crude value, taken from Table 2). (a): Monitoring intervention, (b): Low-sodium seasoning intervention.
Changes in urinary sodium excretion and differences between the intervention and control groups by stratified analysis (mg/day).
| Intervention Group | Control Group | Difference of Change 4) |
| Difference of Change 6) |
| |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
| Baseline 1) | Post Intervention 1) | Change 2) | Change 3) |
| Baseline 1) | Post Intervention 1) | Change 2) | Change 3) | |||||
| Men | 30 | 4646 | 4422 | −224 | 271 8) | 36 | 4533 | 3573 | −960 | −716 8) | 736 | 0.12 | 987 8) | 0.07 |
| (1661) | (1465) | (−828, 381) | (−747, 1289) | (2020) | (1327) | (−1702, −219) | (−1479, 47) | (−228, 1701) | (−90, 2064) | |||||
| Women | 61 | 3688 | 3419 | −270 | −51 8) | 61 | 3505 | 3317 | −188 | 3 8) | −82 | 0.76 | −54 8) | 0.91 |
| (1179) | (1332) | (−650, 110) | (−523, 421) | (1124) | (1305) | (−563, 187) | (−428, 433) | (−610, 447) | (−589, 482) | |||||
| Men | 33 | 4187 | 3849 | −338 | −311 9) | 33 | 4982 | 4069 | −913 | −437 9) | 575 | 0.24 | 126 9) | 0.69 |
| (1293) | (1304) | −940, 265) | (−954, 332) | (2230) | (1587) | (−1694, −132) | (−1012, 139) | (−392, 1543) | (−580, 832) | |||||
| Women | 68 | 3484 | 3222 | −262 | −178 9) | 54 | 3738 | 3551 | −188 | 22 9) | −74 | 0.78 | −199 9) | 0.40 |
| (1161) | (1384) | (−649, 125) | (−560, 205) | (1133) | (1209) | (−543, 167) | (−389, 432) | (−606, 458) | (−676, 278) | |||||
1) Mean (SD); 2) mean (95% CI), change = post-intervention urinary sodium excretion − baseline urinary sodium excretion (mg/day); 3) LS means (95% CI), change = post-intervention urinary sodium excretion − baseline urinary sodium excretion (mg/day); 4) mean (95% CI), difference of change = change in intervention group − change in control group; 5) t-test; 6) LS means (95% CI), difference of change = change in intervention group − change in control group; 7) analysis of covariance; 8) adjusted for alcohol intake, current medication status, residential areas, other intervention, and interaction term of the interventions; 9) adjusted for alcohol intake, current medication status, residential areas, other intervention, baseline urinary sodium excretion, and interaction term of the interventions.
Changes in urinary sodium excretion, and differences between the intervention and control groups for monitoring intervention by stratified whether received seasoning intervention (mg/day).
| Intervention Group | Control Group | Difference of Change 4) |
| Difference of Change 6) |
| |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
| Baseline 1) | Post Intervention 1) | Change 2) | Change 3) |
| Baseline 1) | Post Intervention 1) | Change 2) | Change 3) | |||||
| At the end of the intervention | 41 | 4364 | 3925 | −438 | −303 | 46 | 4072 | 3588 | −485 | −453 | 46 | 0.90 | 150 | 0.69 |
| (1614) | (1465) | (−12, 864) | (−923, 318) | (1843) | (1293) | (−1083, 114) | (−1009, 104) | (−679, 772) | (−604, 905) | |||||
| 6 months after the baseline | 44 | 4227 | 3645 | −583 | −431 | 46 | 4045 | 3824 | −221 | −168 | −361 | 0.36 | −263 | 0.51 |
| (1639) | (1421) | (−61, 1104) | (−1073, 211) | (1802) | (1454) | (−827, 385) | (−767, 431) | (−1150, 427) | (−1053, 527) | |||||
| 12 months after the baseline | 44 | 4227 | 4072 | −155 | −92 | 45 | 4092 | 3880 | −212 | −87 | 57 | 0.86 | −5 | 0.99 |
| (1639) | (1986) | (−244, 554) | (−615, 431) | (1854) | (1491) | (−690, 577) | (−574, 400) | (−576, 689) | (−650, 640) | |||||
| At the end of the intervention | 50 | 3709 | 3605 | −104 | 54 | 51 | 3718.32 | 3253 | −466 | −332 | 362 | 0.27 | 386 | 0.25 |
| (1177) | (1435) | (−364, 572) | (−576, 684) | (1317) | (1323) | (−915, −16) | (−879, 215) | (−279, 1003) | (−282, 1055) | |||||
| 6 months after the baseline | 50 | 3705 | 3608 | −96 | −144 | 49 | 3687 | 3505 | −183 | -85 | 86 | 0.79 | 59 | 0.86 |
| (1182) | (1448) | (−338, 530) | (−701, 421) | (1311) | (1626) | (−682, 312) | (−725, 558) | (−570, 780) | (−627, 747) | |||||
| 12 months after the baseline | 47 | 3735 | 3653 | 81 | 82 | 47 | 3667 | 3598 | −68 | −82 | 145 | 0.66 | 164 | 0.65 |
| (1212) | (1196) | (−488, 326) | (−568, 732) | (1309) | (1487) | (−603, 466) | (−653, 489) | (−514, 813) | (−542, 869) | |||||
1) Mean (SD); 2) mean (95% CI), change = post-intervention urinary sodium excretion − baseline urinary sodium excretion (mg/day); 3) LS means (95% CI), change = post-intervention urinary sodium excretion − baseline urinary sodium excretion (mg/day); 4) mean (95% CI), difference of change = change in intervention group − change in control group; 5) t-tests; 6) LS means adjusted for sex, alcohol intake, current medication status, and residential areas (95% CI), difference of change = change in intervention group – change in control group; 7) analysis of covariance.